SEC Form 4/A · accession 0001996804-26-000010
Neurogene Inc. · NGNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Keith Woods
Director
Period of report
Jun 14, 2024
Accepted (ET)
Jun 16, 2026 · 5:32 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001404644
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $42.59 | Jun 14, 2024 | A | 7,700 | A | — | Jun 14, 2034 | Common Stock | 7,700 | 7,700 | D |
Explanation of responses
- F1This option is fully vested.
Remarks
This Form 4 was originally filed on June 17, 2024 using the incorrect CIK number for the Reporting Person and is being refiled under the correct CIK number. This filing amends and replaces the original filing in its entirety